Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization [RNA-seq]
RNA-seq (gene expression) · mouse · 21 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 21 samples: 7 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalizationCell · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE283694_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1195059 and SRA study SRP549817. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 21 samples.
How we read this: 7 replicated groups read from 21 sample titles; they account for 21 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8669714 M1-1 M1
- GSM8669715 M1-2 M1
- GSM8669716 M1-3 M1
- GSM8669717 M2-1 M2
- GSM8669718 M2-2 M2
- GSM8669719 M2-3 M2
- GSM8669720 M3-1 M3
- GSM8669721 M3-2 M3
- GSM8669722 M3-3 M3
- GSM8669723 M4-1 M4
- GSM8669724 M4-2 M4
- GSM8669725 M4-3 M4
- GSM8669726 M5-1 M5
- GSM8669727 M5-2 M5
- GSM8669728 M5-3 M5
- GSM8669729 M6-1 M6
- GSM8669730 M6-2 M6
- GSM8669731 M6-3 M6
- GSM8669732 M7-1 M7
- GSM8669733 M7-2 M7
- GSM8669734 M7-3 M7
- GSE283696 Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization [CUT&Tag] 33 samples shares il-10r, revitalization, immunotherapy, phagocytosis, leveraging, hysteresis, bacterial, immunity
- GSE283695 Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization [ATACseq] 11 samples shares il-10r, revitalization, immunotherapy, phagocytosis, leveraging, hysteresis, bacterial, immunity
- GSE302715 A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [scRNA-seq] 187 samples shares immunotherapy, leveraging
- GSE234086 The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy 24 samples shares immunotherapy, bacterial
- GSE263625 Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases 19 samples shares immunotherapy, immunity
- GSE280080 Radiotherapy synergizes with AAV-based immunotherapy to program local and systemic antitumor immunity 15 samples shares immunotherapy, immunity
- GSE324687 Eomes sustains progenitor CD4⁺ T helper cells to promote anti-tumor immunity during immunotherapy [scRNA] 16 samples shares immunotherapy, immunity
- GSE330003 A High-Throughput Screen on Primary Glioblastoma-Associated Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy [CUT&Tag] 14 samples shares immunotherapy, phagocytosis
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.